Inflation ( CCPI)25.2% (May 2023)
GDP-12.4% (4Q 2022)
Unemployment4.8% (4Q 2022)
3M T-Bill Rate25.65%
12M T-Bill Rate22.91%
2Y T-Bond Rate29.25%/ 30.00%
4Y T-Bond Rate27.25% / 27.35%
USD/LKR292/293
Reserves $2.75Bn (April 2023)
Cum. Trade Deficit $1,443Mn (April 2023 cumulative)
Cum. Fiscal DeficitLKR 2,300 Bn (Dec 2022)

Sri Lanka ranked as 9th best country that has Responded to the COVID-19

Global IndexesApr 16, 2020
Sri Lanka ranked as 9th best country that has Responded to the COVID-19
This story is available exclusively to charts.lk subscribers. Become an member and start reading now.
Global Response to Infectious Disease (GRIDTM) evaluate the Global Response and Leadership in the COVID-19 Pandemic. New Zealand ranked in 1st place while Singapore and Iceland placed 2nd and 3rd places. South Korea (7th), Sri Lanka (9th), Germany (16th), UK (89th), Italy (93rd), Spain (95th). The reason Sri Lanka responded so well is that Sri Lanka has a public health system that is free for all citizens. Going hand in hand, Sri Lanka has had a free education system until graduate school for the last 60 years; thanks to which it has trained thousands of well-qualified healthcare professionals and paramedical workforce for many decades through well-regulated and state of the art medical faculties covering all regions of the country; all free of charge. The doctors and paramedical staff receive post-graduate training and continuous medical education throughout their career. The island nation also has a robust century-old community health program. Health statistics such as maternal and child mortality rates are the lowest in the region. In fact, comparable to the western world. The life expectancy is highest in the region. The nation is 100% vaccination covered, and all treatments under the extended program of immunization are administered free of charge.

Disclaimer

Charts represents an assessment of the market environment as of the date indicated and it is subject to change; and is not intended to be a forecast of future events or a guarantee of future results. This information should not be relied upon by the reader as research or investment advice regarding the funds or any issuer or security in particular. The strategies discussed are strictly for illustrative and educational purposes and should not be construed as a recommendation to purchase or sell, or an offer to sell or a solicitation of an offer to buy any security. There is no guarantee that any strategies discussed will be effective.

The information presented does not take into consideration commissions, tax implications, or other transactions costs, which may significantly affect the economic consequences of a given strategy or investment decision. This document contains general information only and does not take into account an individual’s financial circumstances. An assessment should be made as to whether the information is appropriate in individual circumstances and consideration should be given to talking to a financial advisor before making an investment decisions.